Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple MyelomaNoopur Raje, James N. Kochenderfer, Jesús G. Berdeja et al.|New England Journal of Medicine|2019Cited by 1.7k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract CancerDo‐Youn Oh, Juan W. Valle, Aiwu Ruth He et al.|NEJM Evidence|2022Cited by 1.1k
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysisMarcus Shaker, Ronna L. Campbell, Chitra Dinakar et al.|Journal of Allergy and Clinical Immunology|2020Cited by 676
Drug allergy: A 2022 practice parameter updateDavid A. Khan, Aleena Banerji, Kimberly G. Blumenthal et al.|Journal of Allergy and Clinical Immunology|2022Cited by 504
Rhinitis 2020: A practice parameter updateMark S. Dykewicz, Dana Wallace, David J. Amrol et al.|Journal of Allergy and Clinical Immunology|2020Cited by 399